These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8467821

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.
    Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W.
    Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354
    [Abstract] [Full Text] [Related]

  • 24. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism.
    Schwarz J, Tatsch K, Arnold G, Ott M, Trenkwalder C, Kirsch CM, Oertel WH.
    Neurology; 1993 Dec; 43(12 Suppl 6):S17-20. PubMed ID: 8264906
    [Abstract] [Full Text] [Related]

  • 25. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
    Boesch SM, Donnemiller E, Müller J, Seppi K, Weirich-Schwaiger H, Poewe W, Wenning GK.
    Mov Disord; 2004 Nov; 19(11):1320-5. PubMed ID: 15390003
    [Abstract] [Full Text] [Related]

  • 26. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
    Brücke T, Podreka I, Angelberger P, Wenger S, Topitz A, Küfferle B, Müller C, Deecke L.
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions.
    Smith FW, Besson JA, Gemmell HG, Sharp PF.
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
    Hwang WJ, Yao WJ, Wey SP, Ting G.
    Eur Neurol; 2004 Dec; 51(1):26-9. PubMed ID: 14631126
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W, Keske U, Hosten N, Mäurer J, Poewe W, Felix R.
    J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.
    Markus HS, Costa DC, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):180-5. PubMed ID: 8126501
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK.
    Neuroimage; 2005 Feb 01; 24(3):822-31. PubMed ID: 15652317
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Bettin S, Kämpfer I, Seese A, Schäfer A, Reuter M, Lössner J, Dietrich J, Wagner A, Knapp WH.
    Nuklearmedizin; 1997 Aug 01; 36(5):167-72. PubMed ID: 9380528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.